Results 131 to 140 of about 15,527,582 (268)

Oligonucleotide Technology – A Research Platform for Chemical Biology

open access: yesCHIMIA, 2001
During the past three decades, considerable progress has been made in the field of oligonucleotide synthesis. Today, oligonucleotides and their derivatives can be prepared by highly optimised, automated procedures. They are used as sophisticated
Robert Häner
doaj  

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Mathematical modeling of high temperature fuel cells

open access: yes, 1981
Thesis (M.S.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 1981.Includes bibliographical references.by Pablo G. Debenedetti.Thesis (M.S.)--Massachusetts Institute of Technology, Dept.
Debenedetti, Pablo G.,1953-
core  

Micellar structures and dynamics in aqueous solutions of PEO-PPO-PEO block copolymers [PDF]

open access: yes, 1999
Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept.
Goldmints, Isabella, 1966-
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Operability studies in heat exchanger networks : analysis, control and synthesis

open access: yes, 1988
Thesis (Sc. D.)--Massachusetts Institute of Technology, Dept.
Calandranis, John Christos
core  

Mechanistic studies on chemical instabilities of recombinant proteins [PDF]

open access: yes, 2009
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2009.Includes bibliographical references.Protein molecules are being widely used as pharmaceuticals for treating diseases ranging from diabetes and haemophilia to ...
Pan, Bin, Ph. D. Massachusetts Institute of Technology
core  

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Hydrodynamic effects on animal cells in microcarrier bioreactors by Matthew Shane Croughan. [PDF]

open access: yes, 1988
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept.
Croughan, Matthew Shane
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy